Brain Irradiation and Tremelimumab in Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer
Interventions: RADIATION: Brain radiotherapy or Stereotactic Radiosurgery|DRUG: Tremelimumab|DRUG: HER2 directed therapy|DRUG: Durvalumab
Sponsor: Memorial Sloan Kettering Cancer Center
Collaborators: MedImmune LLC